Skip to main content
Erschienen in: Acta Diabetologica 5/2017

11.02.2017 | Original Article

Association between type 2 diabetes and cancer incidence in Taiwan: data from a prospective community-based cohort study

verfasst von: Wei-Sin Yang, Pei-Chun Chen, Hung-Ju Lin, Ta-Chen Su, Hsiu-Ching Hsu, Ming-Fong Chen, Yuan-Teh Lee, Kuo-Liong Chien

Erschienen in: Acta Diabetologica | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Aims

Evidence of a role for type 2 diabetes in overall cancer risk and risk for specific types of cancer is limited in ethnic Chinese populations. We therefore investigated whether there is an association between diabetes and cancer incidence in Taiwan.

Methods

This study recruited a total of 3602 adults aged 35 years or over (average 54.9 ± 12.3 years, 52.8% women). Participants with fasting glucose ≥126 mg/dL, or taking hypoglycemic medications, were classed as having type 2 diabetes. Cancer incidence was established through regular follow-up interviews and medical records. Cox proportional hazard regression models were used to examine associations for diabetes with risk of all-cause and site-specific cancers.

Results

During a median of follow-up of 10.5 years, 275 individuals developed cancer, including 157 digestive cancers and 31 urinary cancers. Younger participants (aged < 55 years) with diabetes had a greater risk of all cancers [adjusted relative risk (RR) 3.42; 95% confidence interval (CI), 1.78–6.57], digestive cancers (adjusted RR 2.88; 95% CI 1.15–6.94) and urinary cancers (adjusted RR 13.4; 95% CI 2.70–66.3) compared with individuals in the same age group without diabetes.

Conclusions

Our results clearly demonstrate that middle-aged individuals of Chinese ethnicity with diabetes have a greater risk of all-cause cancer and specific subtypes of cancer.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat American Cancer Society (2015) Global cancer facts and figures, 3rd edn. American Cancer Society, Atlanta American Cancer Society (2015) Global cancer facts and figures, 3rd edn. American Cancer Society, Atlanta
2.
Zurück zum Zitat Shikata K, Ninomiya T, Kiyohara Y (2013) Diabetes mellitus and cancer risk: review of the epidemiological evidence. Cancer Sci 104:9–14CrossRefPubMed Shikata K, Ninomiya T, Kiyohara Y (2013) Diabetes mellitus and cancer risk: review of the epidemiological evidence. Cancer Sci 104:9–14CrossRefPubMed
3.
Zurück zum Zitat Wong KC, Wang Z (2006) Prevalence of type 2 diabetes mellitus of Chinese populations in Mainland China, Hong Kong, and Taiwan. Diabetes Res Clin Pract 73:126–134CrossRefPubMed Wong KC, Wang Z (2006) Prevalence of type 2 diabetes mellitus of Chinese populations in Mainland China, Hong Kong, and Taiwan. Diabetes Res Clin Pract 73:126–134CrossRefPubMed
4.
Zurück zum Zitat Barone BB, Yeh HC, Snyder CF et al (2008) Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 300:2754–2764CrossRefPubMedPubMedCentral Barone BB, Yeh HC, Snyder CF et al (2008) Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 300:2754–2764CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Bensimon L, Yin H, Suissa S, Pollak MN, Azoulay L (2014) Type 2 diabetes and the risk of mortality among patients with prostate cancer. Cancer Causes Control 25:329–338CrossRefPubMed Bensimon L, Yin H, Suissa S, Pollak MN, Azoulay L (2014) Type 2 diabetes and the risk of mortality among patients with prostate cancer. Cancer Causes Control 25:329–338CrossRefPubMed
6.
Zurück zum Zitat Chaudhry ZW, Hall E, Kalyani RR, Cosgrove DP, Yeh HC (2013) Diabetes and pancreatic cancer. Curr Probl Cancer 37:287–292CrossRefPubMed Chaudhry ZW, Hall E, Kalyani RR, Cosgrove DP, Yeh HC (2013) Diabetes and pancreatic cancer. Curr Probl Cancer 37:287–292CrossRefPubMed
7.
Zurück zum Zitat Fang H, Yao B, Yan Y et al (2013) Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis of observational studies. Diabetes Technol Ther 15:914–922CrossRefPubMedPubMedCentral Fang H, Yao B, Yan Y et al (2013) Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis of observational studies. Diabetes Technol Ther 15:914–922CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Giovannucci E (2001) Insulin, insulin-like growth factors and colon cancer: a review of the evidence. Nutr Sci 131:3109S–3120S Giovannucci E (2001) Insulin, insulin-like growth factors and colon cancer: a review of the evidence. Nutr Sci 131:3109S–3120S
9.
Zurück zum Zitat Giovannucci E, Harlan DM, Archer MC et al (2010) Diabetes and cancer: a consensus report. CA Cancer J Clin 60:207–221CrossRefPubMed Giovannucci E, Harlan DM, Archer MC et al (2010) Diabetes and cancer: a consensus report. CA Cancer J Clin 60:207–221CrossRefPubMed
10.
Zurück zum Zitat Nakamura K, Wada K, Tamai Y et al (2013) Diabetes mellitus and risk of cancer in Takayama: a population-based prospective cohort study in Japan. Cancer Sci 104:1362–1367CrossRefPubMed Nakamura K, Wada K, Tamai Y et al (2013) Diabetes mellitus and risk of cancer in Takayama: a population-based prospective cohort study in Japan. Cancer Sci 104:1362–1367CrossRefPubMed
11.
Zurück zum Zitat Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM (2005) Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293:194–202CrossRefPubMed Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM (2005) Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293:194–202CrossRefPubMed
12.
Zurück zum Zitat Tseng CH (2013) Higher risk of mortality from lung cancer in Taiwanese people with diabetes. Diabetes Res Clin Pract 102:193–201CrossRefPubMed Tseng CH (2013) Higher risk of mortality from lung cancer in Taiwanese people with diabetes. Diabetes Res Clin Pract 102:193–201CrossRefPubMed
13.
Zurück zum Zitat Lee YTSFC, Yang CY, Chien KL et al (2000) Chin-Shan community cardiovascular cohort in Taiwan: baseline data and five-year follow-up morbidity and mortality. J Clin Epidemiol 53:836–846 Lee YTSFC, Yang CY, Chien KL et al (2000) Chin-Shan community cardiovascular cohort in Taiwan: baseline data and five-year follow-up morbidity and mortality. J Clin Epidemiol 53:836–846
14.
Zurück zum Zitat Chien KL, Hsu HC, Sung FC, Su TC, Chen MF, Lee YT (2005) Hyperuricemia as a risk factor on cardiovascular events in Taiwan: the Chin-Shan community cardiovascular cohort study. Atherosclerosis 183:147–155CrossRefPubMed Chien KL, Hsu HC, Sung FC, Su TC, Chen MF, Lee YT (2005) Hyperuricemia as a risk factor on cardiovascular events in Taiwan: the Chin-Shan community cardiovascular cohort study. Atherosclerosis 183:147–155CrossRefPubMed
15.
Zurück zum Zitat Saito E, Charvat H, Goto A et al (2016) Burden of cancer associated with type 2 diabetes mellitus in Japan, 2010–2030. Cancer Sci 107:521–527CrossRefPubMedPubMedCentral Saito E, Charvat H, Goto A et al (2016) Burden of cancer associated with type 2 diabetes mellitus in Japan, 2010–2030. Cancer Sci 107:521–527CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Kevin D, Burroughs SED, Carl Barrett J, Taylor Jack A (1999) Insulin-like growth factor-I: A key regulator of human cancer risk? J Natl Cancer Inst 91:579–581CrossRef Kevin D, Burroughs SED, Carl Barrett J, Taylor Jack A (1999) Insulin-like growth factor-I: A key regulator of human cancer risk? J Natl Cancer Inst 91:579–581CrossRef
17.
Zurück zum Zitat Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R (2009) Diabetes and cancer. Endocr Relat Cancer 16:1103–1123CrossRefPubMed Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R (2009) Diabetes and cancer. Endocr Relat Cancer 16:1103–1123CrossRefPubMed
18.
Zurück zum Zitat Tseng CH, Tseng CP, Chong CK et al (2006) Increasing incidence of diagnosed type 2 diabetes in Taiwan: analysis of data from a national cohort. Diabetologia 49:1755–1760CrossRefPubMed Tseng CH, Tseng CP, Chong CK et al (2006) Increasing incidence of diagnosed type 2 diabetes in Taiwan: analysis of data from a national cohort. Diabetologia 49:1755–1760CrossRefPubMed
19.
Zurück zum Zitat Chang CH, Shau WY, Jiang YD et al (2010) Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999–2004: a national health insurance data set study. Diabet Med 27:636–643CrossRefPubMed Chang CH, Shau WY, Jiang YD et al (2010) Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999–2004: a national health insurance data set study. Diabet Med 27:636–643CrossRefPubMed
20.
Zurück zum Zitat Wang M, Hu RY, Wu HB et al (2015) Cancer risk among patients with type 2 diabetes mellitus: a population-based prospective study in China. Sci Rep 5:11503CrossRefPubMedPubMedCentral Wang M, Hu RY, Wu HB et al (2015) Cancer risk among patients with type 2 diabetes mellitus: a population-based prospective study in China. Sci Rep 5:11503CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Yang X, So WY, Ma RC et al (2009) Low LDL cholesterol, albuminuria, and statins for the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry. Diabetes Care 32:1826–1832CrossRefPubMedPubMedCentral Yang X, So WY, Ma RC et al (2009) Low LDL cholesterol, albuminuria, and statins for the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry. Diabetes Care 32:1826–1832CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Yang X, Lee HM, Chan JC (2015) Drug-subphenotype interactions for cancer in type 2 diabetes mellitus. Nat Rev Endocrinol 11:372–379CrossRefPubMed Yang X, Lee HM, Chan JC (2015) Drug-subphenotype interactions for cancer in type 2 diabetes mellitus. Nat Rev Endocrinol 11:372–379CrossRefPubMed
23.
Zurück zum Zitat Chan JC, Malik V, Jia W et al (2009) Diabetes in Asia epidemiology, risk factors, and pathophysiology. JAMA 301:2129–2140CrossRefPubMed Chan JC, Malik V, Jia W et al (2009) Diabetes in Asia epidemiology, risk factors, and pathophysiology. JAMA 301:2129–2140CrossRefPubMed
24.
Zurück zum Zitat Lo SF, Chang SN, Muo CH et al (2013) Modest increase in risk of specific types of cancer types in type 2 diabetes mellitus patients. Int J Cancer 132:182–188CrossRefPubMed Lo SF, Chang SN, Muo CH et al (2013) Modest increase in risk of specific types of cancer types in type 2 diabetes mellitus patients. Int J Cancer 132:182–188CrossRefPubMed
26.
Zurück zum Zitat Golozar A, Liu S, Lin JA, Peairs K, Yeh HC (2016) Does metformin reduce cancer risks? Methodologic considerations. Curr Diabetes Rep 16:4CrossRef Golozar A, Liu S, Lin JA, Peairs K, Yeh HC (2016) Does metformin reduce cancer risks? Methodologic considerations. Curr Diabetes Rep 16:4CrossRef
27.
Zurück zum Zitat Suissa S, Azoulay L (2014) Metformin and cancer: mounting evidence against an association. Diabetes Care 37:1786–1788CrossRefPubMed Suissa S, Azoulay L (2014) Metformin and cancer: mounting evidence against an association. Diabetes Care 37:1786–1788CrossRefPubMed
Metadaten
Titel
Association between type 2 diabetes and cancer incidence in Taiwan: data from a prospective community-based cohort study
verfasst von
Wei-Sin Yang
Pei-Chun Chen
Hung-Ju Lin
Ta-Chen Su
Hsiu-Ching Hsu
Ming-Fong Chen
Yuan-Teh Lee
Kuo-Liong Chien
Publikationsdatum
11.02.2017
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 5/2017
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-017-0966-1

Weitere Artikel der Ausgabe 5/2017

Acta Diabetologica 5/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.